En Es
Categories

Industry News

Luminex Acquires MilliporeSigma Flow Cytometry Portfolio

By Labmedica International staff writers
08 Jan 2019

Image: Luminex has acquired the flow cytometry portfolio of MilliporeSigma (Photo courtesy of iStock).Luminex Corporation (Austin, Texas, USA) has completed its previously announced acquisition of MilliporeSigma's (Burlington, MA, USA) flow cytometry portfolio.

Luminex offers a wide range of solutions applicable in diverse markets, including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. Luminex's newly acquired flow cytometry portfolio includes the Amnis family of imaging flow cytometry products for cell-based analysis, as well as the Guava portfolio of systems based on microcapillary technologies.

"We are pleased to announce the completion of this transaction and excited to welcome the talented MilliporeSigma flow cytometry team to the Luminex family," said Homi Shamir, president and CEO of Luminex. "This acquisition enables us to enhance our existing offering of flow-based detection systems, while simultaneously expanding our direct interactions with researchers conducting cellular analysis."

"The Amnis and Guava products complement our wide range of existing flow-based offerings, further differentiating our portfolio and ensuring we are well-positioned to support customers today and into the future," said Shamir. "With this acquisition, we now have expanded our installed based to include more than 5,000 flow cytometry systems worldwide, adding to our impressive footprint and creating the potential for additional meaningful growth."



E-mail Print
FaceBook Twitter Google+ Linked in

Luminex Corporation

Luminex develops, manufactures, and markets biological testing technologies with applications in clinical diagnostics, pharmaceutical drug discovery, biomedical research, including genomic and proteomic research, personalized medicine, biodefense research, and food safety. The company’s open-architecture xMAP technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately.
More info

Additional news

24 Jun 2019
ACR Releases Second Research Road Map on Medical Imaging AI
The Journal of the American College of Radiology (JACR) has published a report detailing real-world artificial intelligence (AI) challenges and summarizing the priorities for translational research in AI for medical imaging to help accelerate the safe and effective use of AI in clinical practice.
Read More
24 Jun 2019
New AI Tool Helps Detect Brain Aneurysms On CT Angiography Exams
Researchers from Stanford University have developed an artificial intelligence (AI) tool that can help radiologists improve their diagnoses of brain aneurysms by highlighting the areas of a brain scan that are likely to contain an aneurysm.
Read More
24 Jun 2019
Fluoroscopy Equipment Market to Reach USD 7 Billion by 2024
The global fluoroscopy equipment market is projected to grow at a CAGR of 4.4% from USD 5.7 billion in 2019 to USD 7.1 billion by 2024, driven by the advantages of flat panel detectors (FPDs) over image intensifiers, use of fluoroscopy in pain management, reimbursement cuts for analog radiography systems, rising geriatric population, growing prevalence of chronic diseases, and awareness programs, conferences, and funding activities.
Read More
22 Jun 2019
Deep Learning with SPECT MPI Can Help Diagnose Coronary Heart Disease
Researchers from the Cedars-Sinai Medical Center have demonstrated for the first time that deep learning analysis of upright and supine single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) can be used to improve the diagnosis of obstructive coronary artery disease.
Read More
22 Jun 2019
Intelerad to Invest USD 75 Million in New AI Medical Imaging Offerings
Intelerad Medical Systems, a medical imaging software provider that specializes in diagnostic viewing, reporting and collaboration solutions, has announced a USD 75 million R&D investment towards extending its solutions portfolio.
Read More
22 Jun 2019
Global Medical Imaging Equipment Market to Surpass USD 44 Billion by 2025
The global medical imaging equipment market was valued at USD 30.81 billion in 2017 and is expected to grow at a CAGR of 4.6% during the forecast period (2018-2025) to reach USD 44.07 billion by 2025, driven by the increasing incidence of chronic diseases such as liver, cancer, and cardiovascular diseases.
Read More
22 Jun 2019
Increased Monitoring Driving Growth of Global Fetal/Neonatal Equipment Market
The global fetal and neonatal equipment market is projected to grow at a CAGR of 7.4% to reach USD 9.06 billion by 2025, driven mainly by a rise in patient monitoring, especially fetal and neonatal care equipment witnessing increased adoption in basic to advanced equipment across the globe.
Read More
22 Jun 2019
New Augmented Reality Surgical Platform Receives FDA Approval
A new augmented reality (AR) technology platform for surgical applications has received 510(k) clearance for clinical use in the operating room by the US Food and Drug Administration (FDA).
Read More
22 Jun 2019
Demand for Coagulation Testing Driving Global Blood Coagulation Analyzer Market
The global blood coagulation analyzer market is projected to grow at a substantial CAGR of 5.9% over the period 2018 to 2023, driven by its increasing scope, product types, and applications.
Read More
Copyright © 2000-2019 TradeMed.com. All rights reserved. | Terms And Conditions